Greg Zante

Chief Financial Officer, Viking Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$2.6M

Companies

Latest trade

Jul 29, 2026

Companies

Viking Therapeutics, Inc.Chief Financial Officer −$2.8M

Trades

VKTX Sold 21,217 shares at $33.47 $0.7M Jul 29

VKTX Sold 57,661 shares at $32.90 $1.9M Jan 5

VKTX Sold 6,185 shares at $35.00 $0.2M Oct 28

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.